WXFL-10030390

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameWXFL-10030390
Drug Alias NameWX-390WXFL-10030390JYP-0390
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsPI3-kinase class ISerine/threonine-protein kinase mTOR
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsGenital Neoplasms, Female +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCisen Pharmaceutical Co LtdShanghai Jiatan Pharmaceutical Technology Co LtdGuangzhou Jiayue Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Jiatan Pharmaceutical Technology Co LtdCisen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsGenital Neoplasms, Female +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A